Cambridge study: Menopause, sleep, mood & brain volume
- astefanskaia
- Feb 5
- 3 min read
Updated: Feb 6
The study at a glance
Researchers grouped 124,780 women into: pre-menopausal, post-menopausal with no HRT, and post-menopausal women who reported ever using HRT (HRT group). They analyzed self-reported mental health and sleep measures, cognitive task performance, and (in a subset with MRI) gray matter volumes in the hippocampus, entorhinal cortex, and anterior cingulate cortex (ACC).
What they found
1) Mental health symptoms were higher after menopause
Across several measures, post-menopausal women reported higher levels of anxiety and depression than pre-menopausal women.
Importantly, women in the HRT group reported greater mental health challenges than post-menopausal women not using HRT on multiple measures (including “having seen a GP/psychiatrist for nerves, anxiety, tension or depression,” and higher symptom-score composites).
2) Sleep problems increased after menopause
The study found significant group differences in:
Insomnia (more trouble falling asleep or waking at night),
Tiredness, and
Sleep duration (shorter sleep in post-menopausal groups vs pre-menopausal).
The HRT group showed higher tiredness than the other groups, while sleep duration was reduced in both post-menopausal groups, with no difference between HRT vs non-HRT for sleep duration.
3) Cognitive task performance: mostly no clear differences
They assessed prospective memory, digit span, and processing speed. While group effects appeared in the statistical models for some tasks, post-hoc comparisons generally did not survive correction—meaning the study did not find strong, consistent between-group differences on these memory-task outcomes. On cognitive testing, the clearest difference was slower reaction time in the post-menopausal group that did not report HRT use compared with the pre-menopausal group.
4) Brain structure differences in emotion- and memory-related regions
In the MRI subset (10,873 women), gray matter volumes in the hippocampus, entorhinal cortex, and ACC were smaller in post-menopausal women vs pre-menopausal women.
The lowest volumes were observed in the HRT group, and volumes in the hippocampus and ACC were also lower in the HRT group vs the non-HRT post-menopausal group.
The key nuance: this study does not prove HRT causes worse outcomes
The authors explicitly note a major interpretive challenge: this is largely cross-sectional (observational) and can’t cleanly separate whether:
women are prescribed HRT because they already have more depression/anxiety symptoms, or
HRT leads to higher symptom levels.
To probe this, they ran a post-hoc analysis suggesting that women who later started HRT had higher pre-existing psychiatric symptoms at baseline (e.g., “ever seen a GP/psychiatrist…” measures), supporting the idea that baseline differences likely contribute to the HRT-group pattern.
They also list limitations such as UK Biobank representativeness, reliance on self-report grouping, and no data on HRT type.
Why this matters (and what it signals)
The study’s conclusion is direct: menopause is linked to adverse mental health outcomes and reductions in gray matter volume in key brain regions, and HRT did not appear to mitigate these associations in this dataset—while highlighting an unmet need for better mental health support during menopause.
If day-to-day work feels unpredictable—especially when sleep, mood, and energy shift—this paper is a reminder that these are measurable, population-level patterns, not personal failure.
Where Joise fits
Joise is building a “daily focus forecast” from wearable signals so you can plan deep work, meetings, and recovery with less guesswork. If this research resonates, you can join early access.
Read the full study: Emotional and cognitive effects of menopause and hormone replacement therapy — University of Cambridge / UK Biobank analysis.
Comments